Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Aeva Reports Fourth Quarter and Full Year 2024 Results
-
Stonegate Capital Partners Updates Coverage on Aquafil Group (ECNL.MI) Q4 2024
-
Century Communities Sets Date for First Quarter 2025 Earnings Release and Conference Call
-
FIGHT DMD Trial Results Selected for Late-Breaking Presentation at MDA Clinical & Scientific Conference
-
Immunome Reports Full Year 2024 Financial Results and Provides Business Update
-
Trinity Capital Inc. Declares Cash Dividend of $0.51 per Share for the First Quarter of 2025
-
Kevin Bradley Promoted to Chief Financial Officer of Alarm.com
-
IGI Declares Extraordinary Cash Dividend and Regular Ordinary Common Share Dividend
-
Domo Announces Winners of the 2025 Community Ovation Awards
-
SL Green Names Peggy Lamb as Independent Director
-
Everyday Health Group Acquires Leading Digital Media Property theSkimm
-
ESS Schedules Fourth Quarter and Full Year 2024 Financial Results Conference Call
-
Alumis Reports Year End 2024 Financial Results and Highlights Recent Achievements
-
Resources Connection to Announce Fiscal 2025 Third Quarter Results on April 2, 2025
-
TILT Holdings Reports Fourth Quarter and Full Year 2024 Results
-
LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
-
Safe Bulkers Announces Participation in Capital Link’s Investor Conference in New York on Monday, March 31, 2025
-
Breaking research could help to protect immunocompromised children from measles as the disease continues to spread
-
EU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that enCore Energy Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
TFII INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that TFI International Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
FLNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fluence Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
XIFR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that XPLR Infrastructure, LP Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
APP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AppLovin Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
MULN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Mullen Automotive, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
EIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edison International Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
GSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025
-
Diamondback Energy, Inc. Schedules First Quarter 2025 Conference Call for May 6, 2025
-
Great Southern Bancorp, Inc. announces quarterly dividend of $0.40 per common share
-
Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Schedules First Quarter 2025 Conference Call for May 6, 2025
-
iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024
-
scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
7.4% Stake Acquired by Another Institutional Investor in ConnectM, Bringing Total Institutional Ownership to 33%
-
Scholastic Corporation Announces Fourth Quarter Dividend
-
Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections
-
Five Below, Inc. Announces Fourth Quarter and Fiscal 2024 Financial Results
-
Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted to Setmelanotide for Treatment of Hypothalamic Obesity in Japan
-
TWFG Announces Fourth Quarter 2024 and Full Year Results
-
Akebia Therapeutics Announces Proposed Public Offering of Common Stock
-
Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
-
Corvus Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
-
Gatekeeper Unveils LuminIQ, Industry-First Agentic AI Solution for Vendor and Contract Lifecycle Management to Supercharge Team Efficiency
-
Ziegler Closes $83,940,000 Financing for Westminster | 2025
-
TRG ANNOUNCES NEW CEO
-
CVD Equipment Corporation Reports Fourth Quarter and Fiscal Year 2024 Financial Results
-
Citrix and NVIDIA to Deliver AI Virtual Workstations, Enabling Customers to Develop and Securely Deliver AI Applications
-
Shooter Detection Systems to Showcase New Outdoor Gunshot Detection Solution, Enhanced Enterprise Software, and Cloud-Based Detection Solutions at ISC West 2025
-
Inventiva announces the schedule of publication and presentation of its 2024 Full-Year Financial Results
-
Inventiva announces the schedule of publication and presentation of its 2024 Full-Year Financial Results
